The deal size was increased to 11.1M shares from 10.0M and priced below last closing price of $20.10. JPMorgan, Jefferies, TD Cowen and Guggenheim are acting as joint book running managers for the offering.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on MBX:
- MBX Biosciences price target raised to $56 from $38 at Mizuho
- Wedbush sees no threat to Ascendis’ Yorvipath from competitor data
- MBX Biosciences files to sell 10M shares of common stock
- Morning News Wrap-Up: Monday’s Biggest Stock Market Stories!
- MBX Biosciences price target raised to $61 from $38 at Citizens JMP